One Crore Organ Donor Pledges Targeted Through Mankind Pharma’s Angdaan Mahadaan Campaign

The nationwide initiative began with an awareness event engaging more than 25,000 employees, families and communities, with transplant specialists and NOTTO representatives addressing organ donation

Mankind Pharma Limited has launched Angdaan Mahadaan, a nationwide public awareness campaign that aims to inspire one crore Indians to pledge for organ donation.
The campaign seeks to move conversations about organ donation beyond hospitals and healthcare institutions and into homes, families and communities across India.
Angdaan Mahadaan was launched in the presence of transplant specialists and representatives from the National Organ and Tissue Transplant Organisation, also known as NOTTO. The initiative focuses on improving awareness, addressing misconceptions surrounding organ donation and encouraging people to register their decision to become donors.

The campaign began with an Organ Donation Awareness Event hosted by Mankind Pharma that engaged more than 25,000 Mankind employees, their families and extended communities.
Sessions during the event addressed organ donation, transplantation, common myths and facts, and the organ donation landscape in India.
Medical specialists participating in the event included Dr. D.S. Ray, Chief Nephrologist and Head, Renal Transplant Programme, R N Tagore International Institute of Cardiac Sciences, Narayana Health, Kolkata.
Dr. Abhideep Chaudhary, Chairman and HOD, HPB Surgery and Liver Transplantation, BLK Max Super Speciality Hospital, New Delhi, and Dr. Kanika Rastogi from the National Organ and Tissue Transplant Organisation, New Delhi, also participated in the awareness initiative.

The campaign draws attention to patients waiting for organ transplants and the gap between demand for organs and the number of available donors, according to information supplied by the company.
Rajeev Juneja, Vice Chairman and Managing Director, Mankind Pharma Ltd., said, “To give is to live beyond yourself. Through Angdaan Mahadaan, we want to inspire people across India to recognise the extraordinary power of a simple decision: the decision to give someone another chance at life. Our ambition is to motivate 1 crore Indians to pledge for organ donation and make this a movement that creates a lasting legacy of hope.”
Mankind Pharma has set a target of motivating one crore people to register organ donation pledges and encourage others to consider doing the same.

People interested in registering an organ donation pledge can do so through the National Organ and Tissue Transplant Organisation donor pledge facility.
Through Angdaan Mahadaan, the company aims to make organ donation a more widely discussed subject among individuals and families while encouraging people to make an informed decision about pledging.

ABOUT MANKIND PHARMA LIMITED
Mankind Pharma Limited operates across pharmaceutical formulations and consumer healthcare in India, with a focus on the domestic market.
The company is present across acute and chronic therapeutic areas including anti infectives, cardiovascular, gastrointestinal, antidiabetic, neuro and CNS, gynaecology, VMN and respiratory categories.
Its consumer healthcare operations cover categories including condoms, pregnancy detection, emergency contraceptives, antacid powders, vitamin and mineral supplements and anti acne preparations.
Following its acquisition of BSV, the company expanded its presence in the domestic women’s health segment.
According to the supplied company information, Mankind Pharma has a field force of more than 18,500 professionals and reaches over five lakh doctors across urban and rural markets.
The company operates 32 manufacturing facilities in India and seven dedicated research and development facilities supported by more than 740 scientists.

At Prittle Prattle News, featuring you virtuously, we celebrate the commitment and innovation. Led by Editor-in-Chief Smruti Bhalerao, our platform is dedicated to sharing impactful stories that inspire change and create awareness. Follow us on LinkedIn, Instagram, and YouTube for more stories that matter.